RCM
TMO icon

Riverhead Capital Management’s Thermo Fisher Scientific TMO Stock Holding History

Riverhead Capital Management’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		$13.9M Buy
47,772
+494
+1% +$141K 0.51% 31
2019
Q2 		$13.9M Buy
47,278
+18,651
+65% +$5.14M 0.51% 29
2019
Q1 		$7.84M Buy
28,627
+4,051
+16% +$1.01M 0.32% 67
2018
Q4 		$5.5M Buy
24,576
+378
+2% +$88.7K 0.25% 100
2018
Q3 		$5.91M Sell
24,198
-627
-3% -$144K 0.21% 125
2018
Q2 		$5.14M Buy
24,825
+4,312
+21% +$915K 0.2% 133
2018
Q1 		$4.24M Sell
20,513
-600
-3% -$126K 0.18% 157
2017
Q4 		$4.01M Buy
21,113
+4,434
+27% +$849K 0.17% 163
2017
Q3 		$3.16M Sell
16,679
-1,900
-10% -$344K 0.15% 185
2017
Q2 		$3.24M Sell
18,579
-285
-2% -$47.9K 0.16% 175
2017
Q1 		$2.9M Sell
18,864
-4,715
-20% -$721K 0.16% 192
2016
Q4 		$3.33M Buy
23,579
+2,600
+12% +$383K 0.21% 141
2016
Q3 		$3.34M Sell
20,979
-10,646
-34% -$1.64M 0.21% 138
2016
Q2 		$4.67M Sell
31,625
-32,501
-51% -$4.8M 0.15% 186
2016
Q1 		$9.08M Sell
64,126
-3,681
-5% -$493K 0.13% 213
2015
Q4 		$9.62M Sell
67,807
-7,813
-10% -$1.04M 0.14% 187
2015
Q3 		$9.25M Sell
75,620
-916
-1% -$119K 0.15% 213
2015
Q2 		$9.93M Sell
76,536
-34,901
-31% -$4.55M 0.15% 206
2015
Q1 		$15M Sell
111,437
-60,752
-35% -$7.83M 0.23% 134
2014
Q4 		$21.6M Sell
172,189
-19,089
-10% -$2.32M 0.33% 85
2014
Q3 		$23.3M Buy
191,278
+84,618
+79% +$10.3M 0.4% 61
2014
Q2 		$12.6M Buy
106,660
+61,377
+136% +$7.22M 0.24% 120
2014
Q1 		$5.45M Sell
45,283
-17,125
-27% -$2.04M 0.12% 238
2013
Q4 		$6.95M Sell
62,408
-72,592
-54% -$7.22M 0.18% 163
2013
Q3 		$12.4M Buy
135,000
+68,000
+101% +$6.15M 0.4% 68
2013
Q2 		$5.67M Buy
+67,000
New +$5.58M 0.19% 145

Other funds holding TMO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Riverhead Capital Management's TMO Position: Q3 2019 in Review

Riverhead Capital Management increased its Thermo Fisher Scientific (TMO) stake by 1% in Q3 2019, buying an estimated $141K and bringing the position to 47,772 shares worth $13.9M. The position accounts for 0.51% of the portfolio, ranked #31.

Riverhead Capital Management first reported a position in TMO in Q2 2013 and has held it in 26 quarters since. The position peaked at $23.3M in Q3 2014. 1,544 funds tracked by Wall St. Rank hold TMO as of Q3 2019.

  • Riverhead Capital Management held 47,772 shares of Thermo Fisher Scientific worth $13.9M as of Q3 2019.
  • Riverhead Capital Management bought 494 Thermo Fisher Scientific shares in Q3 2019, an estimated $141K.
  • Thermo Fisher Scientific made up 0.51% of Riverhead Capital Management's portfolio in Q3 2019, its #31 holding.
  • Riverhead Capital Management first reported a position in Thermo Fisher Scientific in Q2 2013 and has held it in 26 quarters since.
  • Riverhead Capital Management's Thermo Fisher Scientific position peaked at $23.3M in Q3 2014.
  • 1,544 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q3 2019.

Based on Riverhead Capital Management's 13F filing for Q3 2019, filed 13 Nov 2019.